Targovax Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 20
Employees
  • Stock Symbol
  • TRVX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.77
  • (As of Thursday Closing)

Targovax General Information

Description

Targovax ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
OSL
Primary Office
  • Vollsveien 19
  • Lysaker
  • 1386 Oslo
  • Norway
+47 21 00 00 00

Targovax Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Targovax Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.77 $0.74 $0.62 - $1.29 $66.8M 86.6M 171K -$0.13

Targovax Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 82,893 97,016 58,073 27,045
Revenue 4 66 256 3
EBITDA (10,179) (10,664) (16,642) (17,717)
Net Income (11,030) (11,427) (16,758) (18,053)
Total Assets 53,651 61,000 51,806 61,709
Total Debt 7,246 7,601 6,087 6,090
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Targovax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Targovax‘s full profile, request access.

Request a free trial

Targovax Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Targovax ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to t
Biotechnology
Oslo, Norway
20 As of 2021
000.00
000000000 000.00

0000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
0000000000000
San Carlos, CA
000 As of 0000
00000
00000000 00000

00000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugi
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Targovax Competitors (76)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iovance Biotherapeutics Corporation San Carlos, CA 000 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Boston, MA 0 00000 000000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
0000000 Venture Capital-Backed Houston, TX 00 000.00 000000000 - 000.00
You’re viewing 5 of 76 competitors. Get the full list »

Targovax Executive Team (14)

Name Title Board Seat Contact Info
Øystein Soug Chief Executive Officer
Lone Ottesen Chief Development Officer
Victor Levitsky Ph.D Chief Scientific Officer
Erik Wiklund Ph.D Chief Business Officer
Magnus Jäderberg Chief Medical Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Targovax Board Members (4)

Name Representing Role Since
Anders Tuv Self Board Observer 000 0000
You’re viewing 1 of 4 board members. Get the full list »

Targovax Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Targovax Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 02-Jul-2015 000000000000000000 000.00 Biotechnology Ø000000 0000
To view Targovax’s complete acquisitions history, request access »